Skip to main content
David Cornblath, MD, Neurology, Lutherville, MD

David Reid Cornblath MD

Neurophysiology


Professor of Neurology, Professor of Neurological Surgery, Johns Hopkins University School of Medicine; Director, Neurology EMG Laboratory

Join to View Full Profile
  • 10755 Falls RdLutherville, MD 21093

  • Phone+1 410-583-2727

Dr. Cornblath is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 1978 - 1982
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1977 - 1978
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1977

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1982 - Present
  • MD State Medical License
    MD State Medical License 1982 - 2022
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • PA State Medical License
    PA State Medical License 1980 - 1984
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Top Doctors:Baltimore Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Regional Variation of Guillain-Barré Syndrome  
    David Cornblath, MD, Brain

Press Mentions

  • A Cross-Sectional Study of Ocular Surface Discomfort and Corneal Nerve Dysfunction After Paclitaxel Treatment for Cancer
    A Cross-Sectional Study of Ocular Surface Discomfort and Corneal Nerve Dysfunction After Paclitaxel Treatment for CancerJanuary 19th, 2021
  • Intravenous Immunoglobulin Is Safe and Effective as Maintenance Therapy for Patients with Chronic Inflammatory Demyelinating Polyneuropathy
    Intravenous Immunoglobulin Is Safe and Effective as Maintenance Therapy for Patients with Chronic Inflammatory Demyelinating PolyneuropathyOctober 12th, 2020
  • Final Results from the ProCID Study of Efficacy and Safety of 3 Different Dosages of Panzyga® (NewGam) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Presented at AAN 2020
    Final Results from the ProCID Study of Efficacy and Safety of 3 Different Dosages of Panzyga® (NewGam) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Presented at AAN 2020May 18th, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: